Get all your news in one place.
100's of premium titles.
One app.
Start reading
Chicago Sun-Times
Chicago Sun-Times
National
Karen Weintraub | USA Today

Anti-obesity drug demand expected to skyrocket, but will insurance cover the cost?

The anti-diabetic medication Ozempic (semaglutide) made by Danish pharmaceutical company Novo Nordisk” is being touted for its weight loss capabilities as well, a phenomenon that is causing supply shortages and patients finding out their insurers may not cover the cost. (Getty Images)

Demand for anti-obesity medications is expected to grow exponentially as a shortage eases and new drugs come on the market. 

But the drugs cost $1,000 a month or more and must be taken indefinitely. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.